David Evans - Kepler Cheuvreux
Last quote by David Evans
Apart from the underwhelming Aphinity data, Roche has had some other setbacks. Their impact in the second half might limit Roche's chances of upgrading 2017 guidance.feedback
Jul 19 2017
The latest quote from David Evans is: “The Alcon growth plan is on track. That should reassure the markets.”. It comes from the Novartis sets sights on return to growth in 2018 article. You’ll find on this page 4 articles with David Evans quoted on topics such as Alcon, peak and baf312. David Evans has been quoted 4 times in 4 articles.
Take our quote verification challenge and find out !
Quotes by David Evans
Apr 25 2017
The Alcon growth plan is on track. That should reassure the markets.feedback
Sep 17 2016
We think BAF312 now has a 60 percent chance of $3 billion peak sales. An effective drug in SPMS would have a huge impact.feedback
Sep 15 2016
Alcon will either be fixed or sold.feedback
Check if the quote you read on social networks is authentic
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided